At present, environmental degradation and the consistently growing population are two main
problems on the planet earth. Fulfilling the needs of this growing population is quite difficult …

Antibody based products are not widely available to address multiple global health
challenges due to high costs, limited manufacturing capacity, and long manufacturing lead …

Cholera and malaria are major diseases causing high mortality. The only licensed cholera
vaccine is expensive; immunity is lost in children within 3 years and adults are not fully …

Carrot (Daucus carota L.) is of importance in the molecular farming field as it constitutes the
first plant species approved to produce biopharmaceuticals for human use. In this review …

Background: Growing world population and continuous disease emergence have invited the
development of more efficient new vaccines against a range of diseases. Conventional …

Disease prevention through vaccination is considered to be the greatest contribution to
public health over the past century. Every year more than 100 million children are …

Synucleinopathies are conditions that remain with no available effective treatments thus far.
Immunotherapy is a possible path to fight against such pathologies by inducing antibodies …

SBA-15 ordered mesoporous silica can be considered a promising inorganic nanocarrier
with emerging potential as an oral vaccine adjuvant. In this study, we investigated its …

Carrier proteins that provide an effective and long-term immune response to weak antigens
has become a real breakthrough in the disease prevention, making it available to a wider …

Cross-reacting material 197 (CRM197) is a non-toxic mutant of the diphtheria toxin and is
widely used as a carrier protein in conjugate vaccines. This protein was first obtained from …